193 related articles for article (PubMed ID: 22677638)
1. "Triple-TEN" in the treatment of acute ocular complications from toxic epidermal necrolysis.
Tomlins PJ; Parulekar MV; Rauz S
Cornea; 2013 Mar; 32(3):365-9. PubMed ID: 22677638
[TBL] [Abstract][Full Text] [Related]
2. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
De Rojas MV; Dart JK; Saw VP
Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
[TBL] [Abstract][Full Text] [Related]
4. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Tougeron-Brousseau B; Delcampe A; Gueudry J; Vera L; Doan S; Hoang-Xuan T; Muraine M
Am J Ophthalmol; 2009 Dec; 148(6):852-9.e2. PubMed ID: 19837383
[TBL] [Abstract][Full Text] [Related]
5. Plasmapheresis, Intravenous Immunoglobulins, and Autologous Serum Eyedrops in the Acute Eye Complications of Toxic Epidermal Necrolysis.
Pinna A; Nuvoli E; Blasetti F; Posadinu MA; Boscia F
Eur J Ophthalmol; 2017 Nov; 27(6):658-663. PubMed ID: 28362052
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset.
Araki Y; Sotozono C; Inatomi T; Ueta M; Yokoi N; Ueda E; Kishimoto S; Kinoshita S
Am J Ophthalmol; 2009 Jun; 147(6):1004-11, 1011.e1. PubMed ID: 19285657
[TBL] [Abstract][Full Text] [Related]
7. Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children.
Catt CJ; Hamilton GM; Fish J; Mireskandari K; Ali A
Am J Ophthalmol; 2016 Jun; 166():68-75. PubMed ID: 27018234
[TBL] [Abstract][Full Text] [Related]
8. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series.
Yip LW; Thong BY; Lim J; Tan AW; Wong HB; Handa S; Heng WJ
Allergy; 2007 May; 62(5):527-31. PubMed ID: 17313402
[TBL] [Abstract][Full Text] [Related]
9. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M
Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
[TBL] [Abstract][Full Text] [Related]
11. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and limitation of sutureless amniotic membrane transplantation for acute toxic epidermal necrolysis.
Shay E; Khadem JJ; Tseng SC
Cornea; 2010 Mar; 29(3):359-61. PubMed ID: 20098313
[TBL] [Abstract][Full Text] [Related]
13. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
Di Pascuale MA; Espana EM; Liu DT; Kawakita T; Li W; Gao YY; Baradaran-Rafii A; Elizondo A; Raju VK; Tseng SC
Ophthalmology; 2005 May; 112(5):904-12. PubMed ID: 15878074
[TBL] [Abstract][Full Text] [Related]
14. Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids.
Shammas MC; Lai EC; Sarkar JS; Yang J; Starr CE; Sippel KC
Am J Ophthalmol; 2010 Feb; 149(2):203-213.e2. PubMed ID: 20005508
[TBL] [Abstract][Full Text] [Related]
15. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
16. The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens-Johnson syndrome.
Kim DH; Yoon KC; Seo KY; Lee HS; Yoon SC; Sotozono C; Ueta M; Kim MK
Ophthalmology; 2015 Feb; 122(2):254-64. PubMed ID: 25262319
[TBL] [Abstract][Full Text] [Related]
17. Indications and outcomes of amniotic membrane transplantation in the management of acute stevens-johnson syndrome and toxic epidermal necrolysis: a case-control study.
Hsu M; Jayaram A; Verner R; Lin A; Bouchard C
Cornea; 2012 Dec; 31(12):1394-402. PubMed ID: 23135531
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Effect of a Treatment Protocol for Acute Ocular Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Shanbhag SS; Rashad R; Chodosh J; Saeed HN
Am J Ophthalmol; 2019 Dec; 208():331-341. PubMed ID: 31326519
[TBL] [Abstract][Full Text] [Related]
19. Successful Treatment of Acute Ocular-Involving Toxic Epidermal Necrolysis Using Amniotic Membrane Suture Fixated to Custom Designed Symblepharon Rings.
Cheung CS; Ali A; Chew HF
Cornea; 2016 Apr; 35(4):578-81. PubMed ID: 26863497
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases.
Gregory DG
Ophthalmology; 2011 May; 118(5):908-14. PubMed ID: 21440941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
